Documente Academic
Documente Profesional
Documente Cultură
Factori de risc
Oprirea fumatului
Factori de risc
Morfopatologie
Adenocarcinom pulmonar
Microscopic:
Adenocarcinom pulmonar
Tipuri:
Subtip:
Caracteristici imunohistochimice
Adenocarcinom:
Carcinom epidermoid
Microcelular (neuroendocrin)
TTF1
Manifestri clinice
Manifestri clinice
Tumora primar
Extensie local i regional cu invazia sau obstrucia
structurilor adiacente
Determinri metastatice
Sindroame paraneoplazice
Tumora primar
Tuse, hemoptizie
Wheezing, stridor
Dispnee
Pneumonit obstructiv
Dezvoltare periferic
Extensie regional
Extensie mediastinal:
Extensie regional
Diseminare metastatic
Sindroame paraneoplazice
Sindroame paraneoplazice
Sindroame paraneoplazice
NSCLC
NSCLC
Coagulare:
Diagnostic = bioptic!
Minim invasiv:
Stadializare
Bronhoscopie flexibil
CT / PET-CT (superior)
IRM cerebral
Sistem:
T = tumor
N = nodes (ganglioni)
M = metastaze
metastaze extratoracice
Stadializare fiziologic
Chimioterapie, radioterapie
Datorit:
Vrstei
Evaluare preoperatorie
Contraindicaii absolute: VEMS < 1L, DLco < 40% pred, PaCO2 > 45mmHg
Contraindicaii relative: VEMS prezis postoperator < 1L, DLco ppo < 40%
pred, VO2max < 20 mL/(kg x min)
Boal extins
Management:
Nodul solitar pulmonar
Risc crescut: vrst mai mare, status fumtor (numr PA, fumtor
curent), diametru crescut, margini spiculate
Management NSLC
Stadiul IV metastaze
La distan
Monitorizare postoperatorie
Radioterapie curativ
+/- chimioterapie
Chirurgie dac:
Fr adenopatii controlaterale
Raport risc/beneficiu?
Radioterapie?
Antialgice
Medicamente intite
Anti-angiogenez: bevacizumab
Anti-EGFR
nc n stadiu de cercetare
Managementul SCLC
Chimioterapie
Combinat cu chimioterapia
Screening